1 2929 109 [YOGA TO IMPROVE ASTHMA CONTROL IN SEVERE ASTHMATICS TREATED WITH BIOLOGICS]. WE CONDUCTED A PROSPECTIVE OBSERVATIONAL STUDY TO EVALUATE THE EFFICACY OF YOGA IN POORLY CONTROLLED SEVERE ASTHMATIC PATIENTS TREATED WITH MAXIMAL INHALED THERAPY AND BIOLOGICS. THE OBJECTIVE OF YOGA WAS TO IMPROVE BREATHING CONSCIOUSNESS, EXERCISING CONTROLLED VENTILATION WITH AND WITHOUT RETENTION, ABDOMINAL BREATHING OBSERVATION, IMPROVEMENT OF INSPIRATORY AND EXPIRATORY MUSCLES, OPENING OF THE CHEST, DIAPHRAGM EXERCISES AND RELAXATION. WE MEASURED EXHALED NITRIC OXIDE, FORCED EXPIRATORY VOLUME IN ONE SECOND, FORCED VITAL CAPACITY, ASTHMA CONTROL AND QUALITY OF LIFE QUESTIONNAIRES, ANXIETY AND DEPRESSION QUESTIONNAIRES BEFORE AND AFTER THE TENTH YOGA COURSE (PERFORMED TWICE A WEEK). HALF OF THE PATIENTS WHO WERE INVITED TO PARTICIPATE TO THE STUDY DECLINED DUE TO ORGANIZATION PROBLEMS. TWO PATIENTS WERE EXCLUDED DUE TO BRONCHITIS AND ARTHRALGIA RESPECTIVELY. THE ANALYSIS OF THE DATA FROM 12 PARTICIPANTS REVEALED SIGNIFICANT IMPROVEMENT IN ASTHMA CONTROL AND ASTHMA QUALITY OF LIFE QUESTIONNAIRES AND A REDUCTION OF ANXIETY.THE REGULAR PRACTICE OF YOGA IN SEVERE ASTHMATICS INSUFFICIENTLY CONTROLLED DESPITE MAXIMAL INHALED TREATMENT AND BIOTHERAPY SEEMS TO BE AN INTERESTING COMPLEMENTARY OPTION TO IMPROVE ASTHMA CONTROL. OUR RESULTS MUST BE CONFIRMED IN LARGER RANDOMIZED CONTROLLED TRIALS. 2020 2 1943 39 SAHAJA YOGA IN THE MANAGEMENT OF MODERATE TO SEVERE ASTHMA: A RANDOMISED CONTROLLED TRIAL. BACKGROUND: SAHAJA YOGA IS A TRADITIONAL SYSTEM OF MEDITATION BASED ON YOGIC PRINCIPLES WHICH MAY BE USED FOR THERAPEUTIC PURPOSES. A STUDY WAS UNDERTAKEN TO ASSESS THE EFFECTIVENESS OF THIS THERAPY AS AN ADJUNCTIVE TOOL IN THE MANAGEMENT OF ASTHMA IN ADULT PATIENTS WHO REMAINED SYMPTOMATIC ON MODERATE TO HIGH DOSES OF INHALED STEROIDS. METHODS: A PARALLEL GROUP, DOUBLE BLIND, RANDOMISED CONTROLLED TRIAL WAS CONDUCTED. SUBJECTS WERE RANDOMLY ALLOCATED TO SAHAJA YOGA AND CONTROL INTERVENTION GROUPS. BOTH THE YOGA AND THE CONTROL INTERVENTIONS REQUIRED THE SUBJECTS TO ATTEND A 2 HOUR SESSION ONCE A WEEK FOR 4 MONTHS. ASTHMA RELATED QUALITY OF LIFE (AQLQ, RANGE 0-4), PROFILE OF MOOD STATES (POMS), LEVEL OF AIRWAY HYPERRESPONSIVENESS TO METHACHOLINE (AHR), AND A DIARY CARD BASED COMBINED ASTHMA SCORE (CAS, RANGE 0-12) REFLECTING SYMPTOMS, BRONCHODILATOR USAGE, AND PEAK EXPIRATORY FLOW RATES WERE MEASURED AT THE END OF THE TREATMENT PERIOD AND AGAIN 2 MONTHS LATER. RESULTS: TWENTY ONE OF 30 SUBJECTS RANDOMISED TO THE YOGA INTERVENTION AND 26 OF 29 SUBJECTS RANDOMISED TO THE CONTROL GROUP WERE AVAILABLE FOR ASSESSMENT AT THE END OF TREATMENT. THE IMPROVEMENT IN AHR AT THE END OF TREATMENT WAS 1.5 DOUBLING DOSES (95% CONFIDENCE INTERVAL (CI) 0.0 TO 2.9, P=0.047) GREATER IN THE YOGA INTERVENTION GROUP THAN IN THE CONTROL GROUP. DIFFERENCES IN AQLQ SCORE (0.41, 95% CI -0.04 TO 0.86) AND CAS (0.9, 95% CI -0.9 TO 2.7) WERE NOT SIGNIFICANT (P>0.05). THE AQLQ MOOD SUBSCALE DID IMPROVE MORE IN THE YOGA GROUP THAN IN THE CONTROL GROUP (DIFFERENCE 0.63, 95% CI 0.06 TO 1.20), AS DID THE SUMMARY POMS SCORE (DIFFERENCE 18.4, 95% CI 0.2 TO 36.5, P=0.05). THERE WERE NO SIGNIFICANT DIFFERENCES BETWEEN THE TWO GROUPS AT THE 2 MONTH FOLLOW UP ASSESSMENT. CONCLUSIONS: THIS RANDOMISED CONTROLLED TRIAL HAS SHOWN THAT THE PRACTICE OF SAHAJA YOGA DOES HAVE LIMITED BENEFICIAL EFFECTS ON SOME OBJECTIVE AND SUBJECTIVE MEASURES OF THE IMPACT OF ASTHMA. FURTHER WORK IS REQUIRED TO UNDERSTAND THE MECHANISM UNDERLYING THE OBSERVED EFFECTS AND TO ESTABLISH WHETHER ELEMENTS OF THIS INTERVENTION MAY BE CLINICALLY VALUABLE IN PATIENTS WITH SEVERE ASTHMA. 2002 3 865 36 EFFECT OF YOGA PRACTICES ON PULMONARY FUNCTION TESTS INCLUDING TRANSFER FACTOR OF LUNG FOR CARBON MONOXIDE (TLCO) IN ASTHMA PATIENTS. PRANA IS THE ENERGY, WHEN THE SELF-ENERGIZING FORCE EMBRACES THE BODY WITH EXTENSION AND EXPANSION AND CONTROL, IT IS PRANAYAMA. IT MAY AFFECT THE MILIEU AT THE BRONCHIOLES AND THE ALVEOLI PARTICULARLY AT THE ALVEOLO-CAPILLARY MEMBRANE TO FACILITATE DIFFUSION AND TRANSPORT OF GASES. IT MAY ALSO INCREASE OXYGENATION AT TISSUE LEVEL. AIM OF OUR STUDY IS TO COMPARE PULMONARY FUNCTIONS AND DIFFUSION CAPACITY IN PATIENTS OF BRONCHIAL ASTHMA BEFORE AND AFTER YOGIC INTERVENTION OF 2 MONTHS. SIXTY STABLE ASTHMATIC-PATIENTS WERE RANDOMIZED INTO TWO GROUPS I.E GROUP 1 (YOGA TRAINING GROUP) AND GROUP 2 (CONTROL GROUP). EACH GROUP INCLUDED THIRTY PATIENTS. LUNG FUNCTIONS WERE RECORDED ON ALL PATIENTS AT BASELINE, AND THEN AFTER TWO MONTHS. GROUP 1 SUBJECTS SHOWED A STATISTICALLY SIGNIFICANT IMPROVEMENT (P<0.001) IN TRANSFER FACTOR OF THE LUNG FOR CARBON MONOXIDE (TLCO), FORCED VITAL CAPACITY (FVC), FORCED EXPIRATORY VOLUME IN 1ST SEC (FEV1), PEAK EXPIRATORY FLOW RATE (PEFR), MAXIMUM VOLUNTARY VENTILATION (MVV) AND SLOW VITAL CAPACITY (SVC) AFTER YOGA PRACTICE. QUALITY OF LIFE ALSO INCREASED SIGNIFICANTLY. IT WAS CONCLUDED THAT PRANAYAMA & YOGA BREATHING AND STRETCHING POSTURES ARE USED TO INCREASE RESPIRATORY STAMINA, RELAX THE CHEST MUSCLES, EXPAND THE LUNGS, RAISE ENERGY LEVELS, AND CALM THE BODY. 2012 4 214 31 A STUDY OF THE EFFECT OF YOGA TRAINING ON PULMONARY FUNCTIONS IN PATIENTS WITH BRONCHIAL ASTHMA. THE ROLE OF YOGA BREATHING EXERCISES, AS AN ADJUNCT TREATMENT FOR BRONCHIAL ASTHMA IS WELL RECOGNIZED. ONE HUNDRED TWENTY PATIENTS OF ASTHMA WERE RANDOMIZED INTO TWO GROUPS I.E GROUP A (YOGA TRAINING GROUP) AND GROUP B (CONTROL GROUP). EACH GROUP INCLUDED SIXTY PATIENTS. PULMONARY FUNCTION TESTS WERE PERFORMED ON ALL THE PATIENTS AT BASELINE, AFTER 4 WEEKS AND THEN AFTER 8 WEEKS. MAJORITY OF THE SUBJECTS IN THE TWO GROUPS HAD MILD DISEASE (34 PATIENTS IN GROUP A AND 32 IN GROUP B). GROUP A SUBJECTS SHOWED A STATISTICALLY SIGNIFICANT INCREASING TREND (P < 0.01) IN % PREDICTED PEAK EXPIRATORY FLOW RATE (PEFR), FORCED EXPIRATORY VOLUME IN THE FIRST SECOND (FEV1), FORCED VITAL CAPACITY (FVC), FORCED MID EXPIRATORY FLOW IN 0.25-0.75 SECONDS (FEF25-75) AND FEV1/FVC% RATIO AT 4 WEEKS AND 8 WEEKS AS COMPARED TO GROUP B. THUS, YOGA BREATHING EXERCISES USED ADJUNCTIVELY WITH STANDARD PHARMACOLOGICAL TREATMENT SIGNIFICANTLY IMPROVES PULMONARY FUNCTIONS IN PATIENTS WITH BRONCHIAL ASTHMA. 2009 5 1123 26 EFFICACY OF NATUROPATHY AND YOGA IN BRONCHIAL ASTHMA. THE AIM OF THE STUDY WAS TO TEST THE EFFICACY OF A ONE MONTH IN-PATIENT NATUROPATHY AND YOGA PROGRAMME FOR PATIENTS WITH ASTHMA. RETROSPECTIVE DATA OF 159 BRONCHIAL ASTHMA PATIENTS, UNDERGOING THE NATUROPATHY AND YOGA PROGRAMME, WAS ANALYZED FOR FORCED VITAL CAPACITY, FORCED EXPIRATORY VOLUME AT THE END OF 1 SECOND, MAXIMUM VOLUNTARY VENTILATION AND PEAK EXPIRATORY FLOW RATE ON ADMISSION, 11TH DAY, ON DISCHARGE AND ONCE IN THREE MONTHS FOR THREE YEARS. THE PAIRED SAMPLE T TEST RESULTS SHOWED SIGNIFICANT INCREASE IN THE FORCED VITAL CAPACITY AND FORCED EXPIRATORY VOLUME FROM THE DATE OF ADMISSION UP TO 6TH MONTH (P < 0.0035) POST BONFERRONI CORRECTION. MAXIMUM VOLUNTARY VENTILATION SIGNIFICANTLY INCREASED FROM ADMISSION TILL THE DATE OF DISCHARGE (P < 0.0035) AND PEAK EXPIRATORY FLOW RATE SIGNIFICANTLY INCREASED FROM ADMISSION TILL THE 36TH MONTH OF FOLLOW-UP (P < 0.0035), POST BONFERRONI CORRECTION. THIS VALIDATED THE BENEFICIAL EFFECT OF COMBINING NATUROPATHY AND YOGA FOR THE MANAGEMENT OF BRONCHIAL ASTHMA. 2014 6 787 31 EFFECT OF YOGA BREATHING EXERCISES (PRANAYAMA) ON AIRWAY REACTIVITY IN SUBJECTS WITH ASTHMA. THE EFFECTS OF TWO PRANAYAMA YOGA BREATHING EXERCISES ON AIRWAY REACTIVITY, AIRWAY CALIBRE, SYMPTOM SCORES, AND MEDICATION USE IN PATIENTS WITH MILD ASTHMA WERE ASSESSED IN A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TRIAL. AFTER BASELINE ASSESSMENT OVER 1 WEEK, 18 PATIENTS WITH MILD ASTHMA PRACTISED SLOW DEEP BREATHING FOR 15 MIN TWICE A DAY FOR TWO CONSECUTIVE 2-WEEK PERIODS. DURING THE ACTIVE PERIOD, SUBJECTS WERE ASKED TO BREATHE THROUGH A PINK CITY LUNG (PCL) EXERCISER--A DEVICE WHICH IMPOSES SLOWING OF BREATHING AND A 1:2 INSPIRATION:EXPIRATION DURATION RATIO EQUIVALENT TO PRANAYAMA BREATHING METHODS; DURING THE CONTROL PERIOD, SUBJECTS BREATHED THROUGH A MATCHED PLACEBO DEVICE. MEAN FORCED EXPIRATORY VOLUME IN 1 S (FEV1), PEAK EXPIRATORY FLOW RATE, SYMPTOM SCORE, AND INHALER USE OVER THE LAST 3 DAYS OF EACH TREATMENT PERIOD WERE ASSESSED IN COMPARISON WITH THE BASELINE ASSESSMENT PERIOD; ALL IMPROVED MORE WITH THE PCL EXERCISER THAN WITH THE PLACEBO DEVICE, BUT THE DIFFERENCES WERE NOT SIGNIFICANT. THERE WAS A STATISTICALLY SIGNIFICANT INCREASE IN THE DOSE OF HISTAMINE NEEDED TO PROVOKE A 20% REDUCTION IN FEV1 (PD20) DURING PRANAYAMA BREATHING BUT NOT WITH THE PLACEBO DEVICE. THE USEFULNESS OF CONTROLLED VENTILATION EXERCISES IN THE CONTROL OF ASTHMA SHOULD BE FURTHER INVESTIGATED. 1990 7 2905 33 [LONG-TERM EFFECTS OF BREATHING EXERCISES AND YOGA IN PATIENTS WITH BRONCHIAL ASTHMA]. TO COMPARE THE EFFECTS OF BREATHING EXERCISES (BE) OR YOGA (Y) ON THE COURSE OF BRONCHIAL ASTHMA WE STUDIED 36 SUBJECTS WITH A MILD DISEASE. THE PATIENTS WERE RANDOMLY DIVIDED INTO 3 GROUPS. 2 OF THEM PARTICIPATED IN A 3 WEEKS TRAINING PROGRAM OF BE OR Y WHILE THE THIRD GROUP RESTED WITHOUT ANY ADDITIONAL TREATMENT (CONTROL GROUP, C). AT THE END OF THE TRAINING PERIOD THE PATIENTS WERE ASKED TO PRACTISE BE OR Y ON THEIR OWN. DRUG THERAPY AND LUNG FUNCTION PARAMETERS BEFORE AND AFTER A BETA 2-AGONIST METERED DOSE INHALER (ALBUTEROL, ALB) WERE RECORDED PRIOR TO THE TRAINING PROGRAM AND IN 4 WEEKS INTERVALS FOR 4 MONTHS THEREAFTER. THE RESPONSE TO THE BETA 2-AGONIST WAS DOCUMENTED CONTINUOUSLY IN 28 PATIENTS. THE MENTAL STATE OF THE PATIENTS WAS ELUCIDATED BY QUESTIONNAIRES.--PRIOR TO THE STUDY A SIGNIFICANT EFFECT OF INHALED ALB ON THE FEV1 WAS SHOWN WITHOUT ANY SIGNIFICANT BETWEEN GROUP DIFFERENCES. BOTH, BE AND Y, CAUSED A SIGNIFICANT AMELIORATION OF THE MENTAL STATE BUT ONLY THE BE INDUCED A SIGNIFICANT IMPROVEMENT OF LUNG FUNCTION PARAMETERS COMPARED TO THE INDIVIDUAL BASELINE VALUES. THE FEV1 INCREASED SIGNIFICANTLY BY 356.3 +/- 146.2 ML (P < 0.05) AND THE VC BY 225.0 +/- 65.5 ML (P < 0.01). THESE LONG-TERM CHANGES WERE NOT SIGNIFICANTLY DIFFERENT FROM THE ACTUAL RESPONSE TO ALB. BE DECREASED THE RV SIGNIFICANTLY BY 306.3 +/- 111.6 ML (P < 0.05), AN EFFECT SIGNIFICANTLY HIGHER COMPARED TO THE BETA 2-AGONIST (P < 0.01). BE IN COMBINATION WITH ALB CAUSED AN ADDITIVE EFFECT.(ABSTRACT TRUNCATED AT 250 WORDS) 1994 8 353 32 ASSESSMENT OF THE QUALITY OF LIFE IN PATIENTS WITH BRONCHIAL ASTHMA, BEFORE AND AFTER YOGA: A RANDOMISED TRIAL. YOGA WHICH IS USED AS AN ADJUNCT TREATMENT FOR BRONCHIAL ASTHMA IS GAINING POPULARITY THROUGHOUT THE WORLD. THE OBJECTIVE OF THIS STUDY WAS TO ASSESS THE EFFECT OF YOGA ON QUALITY OF LIFE IN PATIENTS WITH BRONCHIAL ASTHMA. 120 NON-SMOKING MALE AND FEMALE PATIENTS OF ASTHMA IN THE AGE GROUP OF 17-50 YEARS WERE RANDOMIZED INTO TWO GROUPS I.E. GROUP A (YOGA GROUP) AND GROUP B (CONTROL GROUP). ALL PATIENTS REMAINED ON THEIR PRESCRIBED MEDICATION, BUT GROUP A PATIENTS PRACTICED YOGA BREATHING EXERCISES FOR 8 WEEKS. ASTHMA QUALITY OF LIFE QUESTIONNAIRE (AQLQ) AND DIARY RECORD WAS USED TO ASSESS QUALITY OF LIFE, NUMBER AND SEVERITY OF ASTHMATIC ATTACKS, AND THE DOSAGE OF THE MEDICATION REQUIRED AT BASELINE AND AFTER 8 WEEKS. GROUP A SUBJECTS SHOWED A STATISTICALLY SIGNIFICANT IMPROVEMENT IN "SYMPTOMS", "ACTIVITIES" AND "ENVIRONMENTAL" DOMAINS OF AQLQ AT 8 WEEKS (P<0.01) AND SIGNIFICANT REDUCTION IN DAILY NUMBER AND SEVERITY OF ATTACKS, AND THE DOSAGE OF MEDICATION REQUIRED AT 4 AND 8 WEEKS (P<0.01) COMPARED TO THE BASELINE. YOGA BREATHING EXERCISES USED ADJUNCTIVELY WITH STANDARD PHARMACOLOGICAL TREATMENT SIGNIFICANTLY IMPROVED QUALITY OF LIFE IN PATIENTS WITH BRONCHIAL ASTHMA. 2014 9 751 20 EFFECT OF SHORT TERM YOGA PRACTICE ON VENTILATORY FUNCTION TESTS. TWENTYFIVE NORMAL MALE VOLUNTEERS UNDERGOING A TEN WEEKS COURSE IN THE PRACTICE OF YOGA HAVE BEEN STUDIED BY SOME PARAMETERS OF VENTILATORY FUNCTIONS TESTS. THE OBSERVATIONS RECORDED AT THE END OF TEN WEEKS OF THE COURSE HAVE SHOWN IMPROVED VENTILATORY FUNCTIONS IN THE FORM OF LOWERED RESPIRATORY RATE, INCREASED FORCED VITAL CAPACITY, FEV1, MAXIMUM BREATHING CAPACITY AND BREATH HOLDING TIME, WHILE TIDAL VOLUME AND %FEV1, DID NOT REVEAL ANY SIGNIFICANT CHANGE. THUS, A COMBINED PRACTICE OF YOGA SEEMS TO BE BENEFICIAL ON RESPIRATORY EFFICIENCY. 1988 10 351 31 ASSESSMENT OF SIGNIFICANCE OF YOGA ON QUALITY OF LIFE IN ASTHMA PATIENTS: A RANDOMIZED CONTROLLED STUDY. BACKGROUND: ASTHMA IS A CHRONIC INFLAMMATORY RESPIRATORY DISEASE CHARACTERIZED BY PERIODIC ATTACKS OF WHEEZING, SHORTNESS OF BREATH AND A TIGHT FEELING IN THE CHEST. THE CURRENT STUDY IS BASED ON THE EFFECT OF YOGA ON QUALITY OF LIFE IN ASTHMATICS IN NORTHERN INDIA. MATERIALS AND METHODS: A TOTAL OF 300 PARTICIPANTS OF MILD-TO-MODERATE PERSISTENT ASTHMA (FEV1 >60%) AGED BETWEEN 12 AND 60 YEARS WERE RECRUITED FROM THE DEPARTMENT OF PULMONARY MEDICINE. THEIR QUALITY OF LIFE WAS ASSESSED WITH THE HELP OF MINI ASTHMA QUALITY-OF-LIFE QUESTIONNAIRE (AQLQ) AT BASELINE AND THEN AFTER 3(RD) AND 6(TH) MONTH FROM BASELINE. FORTY-FIVE PARTICIPANTS WERE DROPPED OUT DURING THE STUDY WHILE 255 PARTICIPANTS COMPLETED THE STUDY SUCCESSFULLY. RESULTS: IN "THE YOGA GROUP," SIGNIFICANT IMPROVEMENTS WERE FOUND IN ALL THE SUBDOMAINS OF AQLQ AT 3(RD) MONTH AND AT 6(TH) MONTH IN COMPARISON TO "THE CONTROL GROUP." THE NUMBER NEEDED TO TREAT WAS FOUND TO BE 2.67 FOR THE TOTAL AQLQ SCORE WHICH WAS GREATER THAN THE MINIMAL IMPORTANT DIFFERENCE. CONCLUSION: "THE YOGA GROUP" GOT SIGNIFICANTLY BETTER IMPROVEMENT IN ASTHMA QUALITY-OF-LIFE SCORES THAN "THE CONTROL GROUP." THUS, YOGA CAN BE USED AS AN ADJUVANT THERAPY IN THE MANAGEMENT OF ASTHMA. 2017 11 867 39 EFFECT OF YOGA REGIMEN ON LUNG FUNCTIONS INCLUDING DIFFUSION CAPACITY IN CORONARY ARTERY DISEASE PATIENTS: A RANDOMIZED CONTROLLED STUDY. BACKGROUND: LUNG FUNCTIONS ARE FOUND TO BE IMPAIRED IN CORONARY ARTERY DISEASE (CAD), CONGESTIVE HEART FAILURE, LEFT VENTRICULAR DYSFUNCTION, AND AFTER CARDIAC SURGERY. DIFFUSION CAPACITY PROGRESSIVELY WORSENS AS THE SEVERITY OF CAD INCREASES DUE TO REDUCTION IN LUNG TISSUE PARTICIPATING IN GAS EXCHANGE. AIMS AND OBJECTIVES: PRANAYAMA BREATHING EXERCISES AND YOGIC POSTURES MAY PLAY AN IMPRESSIVE ROLE IN IMPROVING CARDIO-RESPIRATORY EFFICIENCY AND FACILITATING GAS DIFFUSION AT THE ALVEOLO-CAPILLARY MEMBRANE. THIS STUDY WAS DONE TO SEE THE EFFECT OF YOGA REGIMEN ON LUNG FUNCTIONS PARTICULARLY DIFFUSION CAPACITY IN CAD PATIENTS. MATERIALS AND METHODS: A TOTAL OF 80 STABLE CAD PATIENTS BELOW 65 YEARS OF AGE OF BOTH SEXES WERE SELECTED AND RANDOMIZED INTO TWO GROUPS OF 40 EACH. GROUP I CAD PATIENTS WERE GIVEN YOGA REGIMEN FOR 3 MONTHS WHICH CONSISTED OF YOGIC POSTURES, PRANAYAMA BREATHING EXERCISES, DIETARY MODIFICATION, AND HOLISTIC TEACHING ALONG WITH THEIR CONVENTIONAL MEDICINE WHILE GROUP II CAD PATIENTS WERE PUT ONLY ON CONVENTIONAL MEDICINE. LUNG FUNCTIONS INCLUDING DIFFUSION CAPACITY WERE RECORDED THRICE IN BOTH THE GROUPS: 0 DAY AS BASELINE, 22(ND) DAY AND ON 90(TH) DAY BY USING COMPUTERIZED MS MEDISOFT CARDIO-RESPIRATORY INSTRUMENT, HYP'AIR COMPACT MODEL OF CARDIO-RESPIRATORY TESTING MACHINE WAS MANUFACTURED BY P K MORGAN, INDIA. THE RECORDED PARAMETERS WERE STATISTICALLY ANALYZED BY REPEATED MEASURES ANOVA FOLLOWED BY TUKEY'S TEST IN BOTH THE GROUPS. CARDIOVASCULAR PARAMETERS WERE ALSO COMPARED BEFORE AND AFTER INTERVENTION IN BOTH THE GROUPS. RESULTS: STATISTICALLY SIGNIFICANT IMPROVEMENTS WERE SEEN IN SLOW VITAL CAPACITY, FORCED VITAL CAPACITY, PEAK EXPIRATORY FLOW RATE, MAXIMUM VOLUNTARY VENTILATION, AND DIFFUSION FACTOR/ TRANSFER FACTOR OF LUNG FOR CARBON MONOXIDE AFTER 3 MONTHS OF YOGA REGIMEN IN GROUP I. FORCED EXPIRATORY VOLUME IN 1(ST) SEC (FEV1), AND FEV1 % ALSO SHOWED A TREND TOWARD IMPROVEMENT ALTHOUGH NOT STATISTICALLY SIGNIFICANT. HR, SBP AND DBP ALSO SHOWED SIGNIFICANT IMPROVEMENT IN GROUP-I PATIENTS WHO FOLLOWED YOGA REGIMEN. CONCLUSIONS: YOGA REGIMEN WAS FOUND TO IMPROVE LUNG FUNCTIONS AND DIFFUSION CAPACITY IN CAD PATIENTS BESIDES IMPROVING CARDIOVASCULAR FUNCTIONS. THUS, IT CAN BE USED AS A COMPLIMENTARY OR ADJUNCT THERAPY ALONG WITH THE CONVENTIONAL MEDICINE FOR THEIR TREATMENT AND REHABILITATION. 2015 12 2547 27 YOGA FOR BRONCHIAL ASTHMA: A CONTROLLED STUDY. FIFTY THREE PATIENTS WITH ASTHMA UNDERWENT TRAINING FOR TWO WEEKS IN AN INTEGRATED SET OF YOGA EXERCISES, INCLUDING BREATHING EXERCISES, SURYANAMASKAR, YOGASANA (PHYSICAL POSTURES), PRANAYAMA (BREATH SLOWING TECHNIQUES), DHYANA (MEDITATION), AND A DEVOTIONAL SESSION, AND WERE TOLD TO PRACTISE THESE EXERCISES FOR 65 MINUTES DAILY. THEY WERE THEN COMPARED WITH A CONTROL GROUP OF 53 PATIENTS WITH ASTHMA MATCHED FOR AGE, SEX, AND TYPE AND SEVERITY OF ASTHMA, WHO CONTINUED TO TAKE THEIR USUAL DRUGS. THERE WAS A SIGNIFICANTLY GREATER IMPROVEMENT IN THE GROUP WHO PRACTISED YOGA IN THE WEEKLY NUMBER OF ATTACKS OF ASTHMA, SCORES FOR DRUG TREATMENT, AND PEAK FLOW RATE. THIS STUDY SHOWS THE EFFICACY OF YOGA IN THE LONG TERM MANAGEMENT OF BRONCHIAL ASTHMA, BUT THE PHYSIOLOGICAL BASIS FOR THIS BENEFICIAL EFFECT NEEDS TO BE EXAMINED IN MORE DETAIL. 1985 13 2786 41 YOGA THERAPY AS AN ADJUVANT IN MANAGEMENT OF ASTHMA. OBJECTIVE: TO ASSESS THE EFFECT OF YOGA ON CONTROL OF ASTHMA IN CHILDREN WITH BRONCHIAL ASTHMA. METHODS: THIS HOSPITAL-BASED INTERVENTIONAL RANDOMIZED CONTROLLED TRIAL CONDUCTED IN THE DEPARTMENT OF PEDIATRICS AT A TERTIARY CARE CENTER OF NORTH INDIA FROM NOVEMBER 2017 TO OCTOBER 2018 ENROLLED 140 NEWLY DIAGNOSED CASES OF ASTHMA OF AGE 10-16 Y WHO WERE RANDOMLY DIVIDED INTO TWO GROUPS. SEVENTY CHILDREN IN THE CASE GROUP PRACTICED YOGA UNDER SUPERVISION FOR A PERIOD OF 3 MO IN ADDITION TO PHARMACOLOGICAL TREATMENT. SEVENTY CONTROLS RECEIVED ONLY PHARMACOLOGICAL TREATMENT. PULMONARY-FUNCTION TESTS WERE DONE AT BASELINE, 6 WK, AND 12 WK ALONG WITH QUALITY OF LIFE (QOL) ASSESSMENT BY PEDIATRIC ASTHMA QUALITY OF LIFE QUESTIONNAIRE (PAQLQ). THE OUTCOME MEASURES ASSESSED WERE FORCED VITAL CAPACITY (FVC), FORCED EXPIRATORY VOLUME IN ONE SECOND (FEV1), FEV1/FVC AND PEAK EXPIRATORY FLOW RATE (PEFR). QOL EVALUATION WAS DONE IN 3 DOMAINS: ACTIVITY LIMITATION, SYMPTOMS, AND EMOTIONAL FUNCTION. RESULTS: THE ASTHMATIC CHILDREN PRACTICING YOGA HAVE SHOWN SIGNIFICANT IMPROVEMENT IN FVC, FEV1, FEV1/FVC AND PEFR WHICH WAS BETTER AS COMPARED TO CONTROLS. IMPROVEMENT WAS ALSO NOTED IN MEAN-PAQLQ SCORE IN CASES WHICH WAS STATISTICALLY SIGNIFICANTLY BETTER AS COMPARED TO CONTROLS. CONCLUSION: YOGA APPEARS TO HAVE SIGNIFICANT POSITIVE EFFECT ON CONTROL OF ASTHMA MEASURED BY PULMONARY-FUNCTION TEST AND QOL. THEREFORE YOGA THERAPY CAN BE RECOMMENDED AS AN ADJUVANT IN MANAGEMENT OF ASTHMA ALONG WITH STANDARD PHARMACOLOGICAL MANAGEMENT. 2021 14 1520 42 IS YOGA TRAINING BENEFICIAL FOR EXERCISE-INDUCED BRONCHOCONSTRICTION? BACKGROUND: SOME STUDIES HAVE SHOWN THE BENEFICIAL EFFECTS OF YOGA FOR INDIVIDUALS WITH BRONCHIAL HYPERREACTIVITY WITH REGARD TO (1) A REDUCTION IN THE USE OF RESCUE MEDICATION, (2) AN INCREASE IN EXERCISE CAPACITY, AND (3) AN IMPROVEMENT IN LUNG FUNCTION. DESPITE THE FACT THAT YOGA IS PROMISING AS A NEW TREATMENT FOR PEDIATRIC PATIENTS, FURTHER STUDIES ARE NEEDED TO ASSESS THE USE OF THIS TRAINING FOR ASTHMA MANAGEMENT. OBJECTIVE: THIS STUDY WAS PERFORMED TO ASSESS THE BENEFICIAL EFFECTS OF YOGA IN EXERCISE-INDUCED BRONCHOCONSTRICTION (EIB) IN CHILDREN. DESIGN: THE STUDY WAS PROSPECTIVE, WITH NO CONTROL GROUP. PARTICIPANTS WERE RANDOMLY CHOSEN AMONG THE NEW PATIENTS AT THE UNIT. SETTING: THIS STUDY WAS CONDUCTED IN THE ERCIYES UNIVERSITY SCHOOL OF MEDICINE, PEDIATRIC ALLERGY UNIT, IN KAYSERI, TURKEY. PARTICIPANTS: TWO GROUPS OF ASTHMATIC CHILDREN AGED 6-17 Y WERE ENROLLED IN THE STUDY: (1) CHILDREN WITH POSITIVE RESPONSES TO AN EXERCISE CHALLENGE (N = 10), AND (2) THOSE WITH NEGATIVE RESPONSES (N = 10). INTERVENTION: BOTH GROUPS ATTENDED 1-H SESSIONS OF YOGA TRAINING 2 X/WK FOR 3 MO. OUTCOME MEASURES: RESEARCHERS ADMINISTERED SPIROMETRIC MEASUREMENT TO ALL CHILDREN BEFORE AND IMMEDIATELY AFTER PARTICIPATING IN AN EXERCISE CHALLENGE. THIS PROCESS WAS PERFORMED AT BASELINE AND AT THE STUDY'S END. AGE, GENDER, IGE LEVELS, EOSINOPHIL NUMBERS, AND SPIROMETRIC MEASUREMENT PARAMETERS INCLUDING FORCED EXPIRATORY VOLUME IN 1 SEC (FEV1), FORCED EXPIRATORY FLOW 25%-75% (FEF25%-75%), FORCED VITAL CAPACITY (FVC), PEAK EXPIRATORY FLOW PERCENTAGE (PEF%), AND PEAK EXPIRATORY FLOW RATE (PEFR) WERE COMPARED USING THE MANN-WHITNEY U TEST AND THE WILCOXON TEST. A P VALUE < .05 WAS CONSIDERED SIGNIFICANT. RESULTS: AT BASELINE, NO SIGNIFICANT DIFFERENCES WERE OBSERVED BETWEEN THE GROUPS REGARDING DEMOGRAPHICS OR PRE-EXERCISE SPIROMETRIC MEASUREMENTS (P > .05, MANN-WHITNEY U TEST). LIKEWISE, NO SIGNIFICANT DIFFERENCES IN SPIROMETRIC MEASUREMENTS EXISTED BETWEEN THE GROUPS REGARDING THE CHANGE IN RESPONSES TO AN EXERCISE CHALLENGE AFTER YOGA TRAINING (P > .05, WILCOXON TEST). FOR THE EXERCISE-RESPONSE-POSITIVE GROUP, THE RESEARCH TEAM OBSERVED A SIGNIFICANT IMPROVEMENT IN MAXIMUM FORCED EXPIRATORY VOLUME 1% (FEV1%) FALL FOLLOWING THE EXERCISE CHALLENGE AFTER YOGA TRAINING (P > .05, WILCOXON TEST). ALL EXERCISE-RESPONSE-POSITIVE ASTHMATICS BECAME EXERCISERESPONSE-NEGATIVE ASTHMATICS AFTER YOGA TRAINING. CONCLUSION: THIS STUDY SHOWED THAT TRAINING CHILDREN IN THE PRACTICE OF YOGA HAD BENEFICIAL EFFECTS ON EIB. IT IS THE RESEARCH TEAM'S OPINION THAT YOGA TRAINING CAN SUPPLEMENT DRUG THERAPY TO ACHIEVE BETTER CONTROL OF ASTHMA. 2014 15 880 24 EFFECT OF YOGA TRAINING ON HANDGRIP, RESPIRATORY PRESSURES AND PULMONARY FUNCTION. ALTHOUGH THERE ARE A NUMBER OF REPORTS ON THE EFFECT OF YOGA TRAINING ON PULMONARY FUNCTIONS, VERY FEW STUDIES HAVE BEEN UNDERTAKEN ON THE EFFECT OF YOGA TRAINING ON RESPIRATORY PRESSURES AND HANDGRIP ENDURANCE. HENCE THE PRESENT WORK WAS PLANNED TO STUDY THE EFFECT OF YOGA TRAINING ON HAND GRIP STRENGTH (HGS), HAND GRIP ENDURANCE (HGE), MAXIMUM EXPIRATORY PRESSURE (MEP), MAXIMUM INSPIRATORY PRESSURE (MIP), FORCED EXPIRATORY VOLUME (FEV), FORCED EXPIRATORY VOLUME IN FIRST SECOND (FEV1) AND PEAK EXPIRATORY FLOW RATE (PEFR). 20 SCHOOL CHILDREN IN THE AGE GROUP OF 12 TO 15 YEARS WERE GIVEN YOGA TRAINING (ASANS AND PRANAYAMS) FOR 6 MONTHS. 20 AGE AND GENDER-MATCHED STUDENTS FORMED THE CONTROL GROUP. YOGA TRAINING PRODUCED STATISTICALLY SIGNIFICANT (P < 0.05) INCREASE IN HGS AND HGE. MEP, MIP, FEV, FEV1 AND PEFR ALSO INCREASED SIGNIFICANTLY (P < 0.001) AFTER THE YOGA TRAINING. IN CONTRAST, THE INCREASE IN THESE PARAMETERS IN THE CONTROL GROUP WAS STATISTICALLY INSIGNIFICANT. OUR STUDY SHOWS THAT YOGA TRAINING FOR 6 MONTHS IMPROVES LUNG FUNCTION, STRENGTH OF INSPIRATORY AND EXPIRATORY MUSCLES AS WELL AS SKELETAL MUSCLE STRENGTH AND ENDURANCE. IT IS SUGGESTED THAT YOGA BE INTRODUCED AT SCHOOL LEVEL IN ORDER TO IMPROVE PHYSIOLOGICAL FUNCTIONS, OVERALL HEALTH AND PERFORMANCE OF STUDENTS. 2003 16 572 17 DEFINITION OF A YOGA BREATHING (PRANAYAMA) PROTOCOL THAT IMPROVES LUNG FUNCTION. THIS STUDY TESTS THE HYPOTHESIS THAT YOGA BREATHING (PRANAYAMA) IMPROVES LUNG FUNCTION IN HEALTHY VOLUNTEERS DURING A 6-WEEK PROTOCOL. A RANDOMIZED CONTROLLED PILOT STUDY DEMONSTRATED AN IMPROVEMENT IN PEAK EXPIRATORY FLOW RATE AND FORCED EXPIRATORY VOLUME. THE EASY-TO-LEARN APPROACH CAN BE TRANSLATED TO THE INPATIENT AND OUTPATIENT SETTINGS. 2019 17 316 25 AN INTEGRATED APPROACH OF YOGA THERAPY FOR BRONCHIAL ASTHMA: A 3-54-MONTH PROSPECTIVE STUDY. AFTER AN INITIAL INTEGRATED YOGA TRAINING PROGRAM OF 2 TO 4 WEEKS, 570 BRONCHIAL ASTHMATICS WERE FOLLOWED UP FOR 3 TO 54 MONTHS. THE TRAINING CONSISTED OF YOGA PRACTICES--YOGASANAS, PRANAYAMA, MEDITATION, AND KRIYAS--AND THEORY OF YOGA. RESULTS SHOW HIGHLY SIGNIFICANT IMPROVEMENT IN MOST OF THE SPECIFIC PARAMETERS. THE REGULAR PRACTITIONERS SHOWED THE GREATEST IMPROVEMENT. PEAK EXPIRATORY FLOW RATE (PFR) VALUES SHOWED SIGNIFICANT MOVEMENT OF PATIENTS TOWARD NORMALCY AFTER YOGA, AND 72, 69, AND 66% OF THE PATIENTS HAVE STOPPED OR REDUCED PARENTERAL, ORAL, AND CORTISONE MEDICATION, RESPECTIVELY. THESE RESULTS ESTABLISH THE LONG-TERM EFFICACY OF THE INTEGRATED APPROACH OF YOGA THERAPY IN THE MANAGEMENT OF BRONCHIAL ASTHMA. 1986 18 2803 18 YOGA THERAPY IN CHRONIC BRONCHITIS. FIFTEEN PATIENTS OF CHRONIC BRONCHITIS RECEIVED YOGA THERAPY IN THE FORM OF PRANAYAM AND 8 TYPES OF 'ASANS' FOR A PERIOD OF 4 WEEKS. THEY HAD A PERCEPTIBLE IMPROVEMENT IN DYSPNOEA AS WAS MEASURED BY VISUAL ANALOG. LUNG FUNCTION PARAMETERS (VC, FEV1, AND PEFR) ALSO IMPROVED AFTER THE PRACTICE OF YOGA. THIS PRELIMINARY STUDY INDICATES THAT, YOGA MAY BE AN USEFUL ADJUNCT TO OTHER CONVENTIONAL FORM OF THERAPY FOR COPD. 1998 19 792 35 EFFECT OF YOGA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE. YOGA IS ADJUNCTIVELY UTILIZED OUTSIDE THE UNITED STATES IN THE TREATMENT OF A VARIETY OF DISEASES, INCLUDING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BUT THERE ARE NO STUDIES ASSESSING ITS ADJUNCTIVE EFFICACY IN THE UNITED STATES. WE PROSPECTIVELY EVALUATED THE EFFECTS OF YOGA TRAINING ON THE QUALITY OF LIFE (QOL) AND THE PARAMETERS OF LUNG FUNCTION IN PATIENTS WITH COPD. THIRTY-THREE PATIENTS WITH DOCUMENTED COPD, PER GLOBAL INITIATIVE FOR OBSTRUCTIVE LUNG DISEASE CRITERIA, WERE RECRUITED. ALL PATIENTS RECEIVED STANDARD COPD CARE. THE QOL WAS ASSESSED BY THE ST. GEORGE RESPIRATORY QUESTIONNAIRE. STANDARD SPIROMETRY AND MAXIMUM INSPIRATORY (MAXIMAL INSPIRATORY PRESSURE) AND EXPIRATORY PRESSURE (MAXIMAL EXPIRATORY PRESSURE) WERE MEASURED. PATIENTS WERE TAUGHT SELECTED YOGA EXERCISES INCLUDING BREATHING EXERCISES, MEDITATION, AND YOGA POSTURES FOR 1 HOUR, THRICE A WEEK FOR 6 WEEKS BY A CERTIFIED YOGA THERAPIST. THE QUALITY OF LIFE AND LUNG FUNCTION WERE AGAIN ASSESSED AT THE END OF 6 WEEKS. TWENTY-TWO PATIENTS COMPLETED THE STUDY. DIFFERENCES IN PREYOGA VERSUS POSTYOGA SCORES WERE EVALUATED USING PAIRED T-TESTS. STATISTICALLY SIGNIFICANT IMPROVEMENTS (P < 0.05) WERE OBSERVED FOR THE ST. GEORGE RESPIRATORY QUESTIONNAIRE [95% CONFIDENCE INTERVAL (CI) 43.13-58.47], VITAL CAPACITY (95% CI 2.53-7.65), MAXIMAL INSPIRATORY PRESSURE (95% CI 6.62-23.64), AND MAXIMAL EXPIRATORY PRESSURE (95% CI 1.63-13.81). YOGA WHEN PRACTICED BY PATIENTS WITH COPD RESULTS IN IMPROVEMENT IN THE QOL AND LUNG FUNCTION ON A SHORT-TERM BASIS. ADDITIONAL RESEARCH IS NEEDED TO CONFIRM THESE FINDINGS IN A RANDOMIZED CONTROLLED TRIAL AND IN THE LONGER TERM. 2012 20 1184 21 EVALUATION OF YOGA THERAPY PROGRAMME FOR PATIENTS OF BRONCHIAL ASTHMA. A STUDY OF THE EFFECT OF YOGA THERAPY PROGRAMME ON 46 INDOOR PATIENTS OF CHRONIC BRONCHIAL ASTHMA ON EXERCISE CAPACITY, PULMONARY FUNCTIONS AND BLOOD GASES WAS CONDUCTED. EXERCISE CAPACITY WAS MEASURED BY 3 TESTS: (I) 12 MIN WALK TEST (12-MD); (II) PHYSICAL FITNESS INDEX (PFI) BY MODIFIED HARVARD STEP TEST; AND (III) EXERCISE-LIABILITY INDEX (ELI). YOGA THERAPY PROGRAMME RESULTED IN A SIGNIFICANT INCREASE IN THE PULMONARY FUNCTIONS AND EXERCISE TOLERANCE. A ONE-YEAR FOLLOW-UP STUDY SHOWED A GOOD TO FAIR RESPONSE WITH REDUCED SYMPTOMS SCORE AND DRUG REQUIREMENTS IN THESE SUBJECTS. IT IS CONCLUDED THAT YOGA THERAPY IS BENEFICIAL FOR BRONCHIAL ASTHMA. 1993